Furthermore, disease-specific survival (DSS) analysis in pan-cancer indicated that TMEM44 acted as an independent predictor in ACC, KIRC, LGG, LIHC, LUSC, and MESO based on COX analysis (P < 0.05) (Fig. 2F). This evidence concerns the gene TMEM44 and cancer.